Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments
- PMID: 34177601
- PMCID: PMC8222915
- DOI: 10.3389/fphar.2021.692614
Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments
Abstract
Background: Chronic Bacterial Prostatitis (CBP) is an inflammatory condition caused by a persistent bacterial infection of the prostate gland and its surrounding areas in the male pelvic region. It is most common in men under 50 years of age. It is a long-lasting and debilitating condition that severely deteriorates the patient's quality of life. Anatomical limitations and antimicrobial resistance limit the effectiveness of antibiotic treatment of CBP. Bacteriophage therapy is proposed as a promising alternative treatment of CBP and related infections. Bacteriophage therapy is the use of lytic bacterial viruses to treat bacterial infections. Many cases of CBP are complicated by infections caused by both nosocomial and community acquired multidrug resistant bacteria. Frequently encountered strains include Vancomycin resistant Enterococci, Extended Spectrum Beta Lactam resistant Escherichia coli, other gram-positive organisms such as Staphylococcus and Streptococcus, Enterobacteriaceae such as Klebsiella and Proteus, and Pseudomonas aeruginosa, among others. Case Presentation: We present a patient with the typical manifestations of CBP. The patient underwent multiple courses of antibiotic treatment without any long-term resolution of his symptoms. Testing of prostatic secretion and semen samples revealed pathogenic bacteria in each case, which collectively included members of the Staphylococcal species such as Methicillin resistant Staphylococcus aureus (MRSA) and Staphylococcus haemolyticus, Enterococcus faecalis, and Streptococcus mitis, among others. Methods and Outcome: Bacteriophage preparations from the Eliava Institute were used to treat the patient after establishing phage sensitivity to the pathogenic bacteria. Significant improvements in symptoms and re-testing of samples after bacteriophage treatment indicated a reduction in the bacterial load and resolution of the infection. Discussion: The patient saw significant improvement of symptoms, and positive dynamics in bacterial titers and ultrasound controls after phage therapy. The failure of antibiotic therapy and subsequent success of bacteriophage therapy in treating chronic bacterial prostatitis shows the effectiveness of bacteriophages in controlling chronic infections in areas of low vascularity and anatomical complexity. These cases also highlight the efficacy of phages in overcoming antibiotic-resistant infections as well as biofilm infections.
Keywords: antibiotic resistance; bacteriophages; biofilm; case report; chronic bacterial prostatitis; phage therapy.
Copyright © 2021 Johri, Johri, Hoyle, Pipia, Nadareishvili and Nizharadze.
Conflict of interest statement
NH, LP, LN and DN are paid employees of the Eliava Phage Therapy Center. AVJ and PJ are joint owners of Vitalis Phage Therapy. While these are commercial interests of the authors, the study was conducted in the absence of commercial or financial relationships that could be construed as potential conflict of interest.
Figures
Similar articles
-
Case report: Successful treatment of recurrent E. coli infection with bacteriophage therapy for patient suffering from chronic bacterial prostatitis.Front Pharmacol. 2023 Sep 18;14:1243824. doi: 10.3389/fphar.2023.1243824. eCollection 2023. Front Pharmacol. 2023. PMID: 37790805 Free PMC article.
-
[Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].Mikrobiyol Bul. 2016 Apr;50(2):215-23. doi: 10.5578/mb.24165. Mikrobiyol Bul. 2016. PMID: 27175494 Turkish.
-
Multidisciplinary approach to prostatitis.Arch Ital Urol Androl. 2019 Jan 18;90(4):227-248. doi: 10.4081/aiua.2018.4.227. Arch Ital Urol Androl. 2019. PMID: 30655633
-
The perspectives of the application of phage therapy in chronic bacterial prostatitis.FEMS Immunol Med Microbiol. 2010 Nov;60(2):99-112. doi: 10.1111/j.1574-695X.2010.00723.x. Epub 2010 Aug 3. FEMS Immunol Med Microbiol. 2010. PMID: 20698884 Review.
-
Antimicrobial resistance in gram-positive bacteria.Am J Med. 2006 Jun;119(6 Suppl 1):S11-9; discussion S62-70. doi: 10.1016/j.amjmed.2006.03.012. Am J Med. 2006. PMID: 16735146 Review.
Cited by
-
Advances in bacteriophage-mediated strategies for combating polymicrobial biofilms.Front Microbiol. 2024 Jan 5;14:1320345. doi: 10.3389/fmicb.2023.1320345. eCollection 2023. Front Microbiol. 2024. PMID: 38249486 Free PMC article. Review.
-
Phages as potential life-saving therapeutic option in the treatment of multidrug-resistant urinary tract infections.Acta Biochim Pol. 2025 Feb 11;72:14264. doi: 10.3389/abp.2025.14264. eCollection 2025. Acta Biochim Pol. 2025. PMID: 40007695 Free PMC article. Review.
-
Bacteriophage therapy for drug-resistant Staphylococcus aureus infections.Front Cell Infect Microbiol. 2024 Jan 31;14:1336821. doi: 10.3389/fcimb.2024.1336821. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38357445 Free PMC article. Review.
-
Successful use of a phage endolysin for treatment of chronic pelvic pain syndrome/chronic bacterial prostatitis.Front Med (Lausanne). 2023 Aug 15;10:1238147. doi: 10.3389/fmed.2023.1238147. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37649979 Free PMC article.
-
Phage Therapy in the Management of Urinary Tract Infections: A Comprehensive Systematic Review.Phage (New Rochelle). 2023 Sep 1;4(3):112-127. doi: 10.1089/phage.2023.0024. Epub 2023 Sep 20. Phage (New Rochelle). 2023. PMID: 37771568 Free PMC article.
References
-
- Carlton R. M. (1999). Phage Therapy: Past History and Future Prospects. Arch. Immunol. Ther. Exp. (Warsz) 47, 267–274. - PubMed
Publication types
LinkOut - more resources
Full Text Sources